Jaguar Animal Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

jaguaranimalhealth.com

Stage

IPO | IPO

Total Raised

$11.62M

Date of IPO

5/13/2015

Market Cap

0.03B

Stock Price

0.39

About Jaguar Animal Health

Jaguar Animal Health is committed to bringing naturally derived important health solutions to all animals of the world, as pharmaceuticals, food additives, and nutraceuticals. Jaguar merges the high-value business model of companion and competitive animal care with the higher-volume economically driven business model applied to the food/farm animal marketplace. Jaguar expects to introduce its first products for animals experiencing watery diarrhea in 2014, both under its own label and in conjunction with private-label marketers.

Jaguar Animal Health Headquarter Location

185 Berry Street Suite 1300

San Francisco, California, 94107,

United States

415-371-8300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Jaguar Animal Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jaguar Animal Health is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Jaguar Animal Health Patents

Jaguar Animal Health has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/24/2016

Ethology, Diabetes, Dietary supplements, Amines, Phenols

Application

Application Date

2/24/2016

Grant Date

Title

Related Topics

Ethology, Diabetes, Dietary supplements, Amines, Phenols

Status

Application

Latest Jaguar Animal Health News

Animal Auto-Immune Disease Therapeutics Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2026

Mar 14, 2022

Search jobs 14-Mar-2022 Animal Auto-Immune Disease Therapeutics Market In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2026 Animal Auto-immune Disease Therapeutics Market: Regional Overview Region wise, the global Animal Auto-immune Disease Therapeutics Market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America leads the global Animal Auto-immune Disease Therapeutics Market followed by Europe. This is due to the extent of awareness for the zoonotic disease transfer in the developed countries like U.S., Canada, Germany, U.K., etc. Asia Pacific and Africa market are witnessing increased adoption of animal healthcare service especially for livestock animal owing to increasing demand for meat products in pharmaceutical and cosmetic industry. Moreover, the increasing threat of zoonotic disease transfer in livestock animal is expected to boost the demand of animal autoimmune disease therapeutics market during the forecast period. Autoimmune disease can be termed as the diseases condition in which the body has a tendency to kill, or affect its own normal cells. In humans there are around 80 types of different auto immune diseases. Similar type of diseases are also observed in animals. Some of the popular autoimmune diseases in animals are Pemphigus Vulgaris, Autoimmune haemolytic anemia (AIHA), dry eye, Addison’s disease, Canine inflammatory bowel disease, Canine systemic lupus, Rheumatoid Arthritis, Allergies (a hypersensitive immune system) and others. There are several ways of treating the auto immune diseases in animals using various drugs and other therapies like surgeries and stem cell therapies. The drugs used in the treatment are just to reduce the symptoms associated with the specific auto immune disease. Animal Auto-immune Disease Therapeutics Market: Drivers and Restraints The increasing transfer of zoonotic diseases among immunosuppressed patient is a prime factor responsible for the increased awareness of the auto-immune disease among companion animals. High threat of HIV transfer from the animal source to a person with suppressed immunity, transfer of allergic components from companion animal to family members are also increasing the demand for diagnosis for autoimmune disease diagnosis among companion animal. The growing incidence of autoimmune diseases in livestock animal has decreased the quality of meat consumed especially in pharmaceutical manufacturing. . Moreover, the increasing focus on livestock health among African countries which are the main exporters of livestock is increasing the demand for autoimmune disease therapy. However limited therapy options for animals in the developing countries and lack of awareness is hindering the growth of animals autoimmune therapeutics market. To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2462 Animal Auto-immune Disease Therapeutics Market: Overview Autoimmune disease treatment is gaining more attention owing to increased threat of zoonotic disease transfer among human. The growing incidence of zoonotic disease transfer is changing business operations of the animal healthcare industry as emergency care. The veterinary hospitals are offering a wide range of therapeutic services for companion animals. However, limited intervention by the government to promote the clinical diagnosis of animal, lack of effective molecular-based technologies to diagnose the autoimmune condition is curbing the growth of animal autoimmune disease diagnostics market. Animal Auto-immune Disease Therapeutics Market: Key Players Some of the key players in global Animal Auto-immune Disease Therapeutics Market are Aratana Therapeutics Inc., Pfizer Inc., Vet-Stem, Inc., Ambrx Inc., Taconic Biosciences, Inc., JBS United, Virbac, Eli Lilly and Company, Jaguar Animal Health Inc. and many more. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications. The report covers exhaustive analysis on: Market Segments Eastern Europe (Russia, Poland, Rest Of Eastern Europe) Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand) Japan Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA) The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2462 Animal Auto-immune Disease Therapeutics Market: Segmentation The global Animal Auto-immune Disease Therapeutics Market has been classified on the basis of product type, disease indication, end user and geography. Based on therapy type, the global Animal Auto-immune Disease Therapeutics Market is divided into following: Corticosteroids

  • Where is Jaguar Animal Health's headquarters?

    Jaguar Animal Health's headquarters is located at 185 Berry Street, San Francisco.

  • What is Jaguar Animal Health's latest funding round?

    Jaguar Animal Health's latest funding round is IPO.

  • How much did Jaguar Animal Health raise?

    Jaguar Animal Health raised a total of $11.62M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.